Biotest Aktiengesellschaft (FRA:BIO)

FRA:BIO Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.8	107.8	108.1	116.6	104.4	71.3
Short-Term Investments	-	11.7	10.4	12.4	8.7	12.3
Cash & Short-Term Investments	41.8	119.5	118.5	129	113.1	83.6
Cash Growth	-50.65%	0.84%	-8.14%	14.06%	35.29%	14.05%
Accounts Receivable	195	193.9	196.8	159.7	146.4	162.1
Other Receivables	1.9	12.9	10	20.2	8.6	17.1
Receivables	196.9	206.8	206.8	179.9	155	179.2
Inventory	523.7	479.5	419.1	293.8	244.6	290.1
Prepaid Expenses	-	-	-	-	5.8	-
Other Current Assets	26.3	3.7	12.1	16.7	3.7	3.4
Total Current Assets	788.7	809.5	756.5	619.4	522.2	556.3
Property, Plant & Equipment	566.8	485.3	475.7	460.3	476.7	311.3
Long-Term Investments	2.1	2.1	11.3	5.1	4.6	2.6
Goodwill	-	6	6	7.2	7.1	7.1
Other Intangible Assets	16.3	1.7	2.1	2.4	3.3	4.3
Long-Term Deferred Tax Assets	28.5	19.5	32.9	0.7	10.2	9.5
Long-Term Deferred Charges	-	3.9	1	0.5	-	-
Other Long-Term Assets	14.1	90.7	108.8	94.3	74.6	240.2
Total Assets	1,417	1,434	1,411	1,203	1,104	1,131
Accounts Payable	83.6	88.4	78.1	51.1	38.8	42
Accrued Expenses	-	5.6	7.6	6.8	9.5	5.9
Current Portion of Long-Term Debt	-	30.4	254.7	26.7	30	21.3
Current Portion of Leases	-	5.5	5.4	4.6	4.8	4.4
Current Income Taxes Payable	0.2	1.1	0.9	0.3	0.5	1.2
Current Unearned Revenue	2.7	4.4	2.9	2.9	2.1	1.8
Other Current Liabilities	44.7	24.7	35.7	37.8	20.7	29
Total Current Liabilities	160.1	160.1	385.3	130.2	106.4	105.6
Long-Term Debt	639.8	582.9	377.3	588.4	474.4	439.5
Long-Term Leases	-	53	52.4	24.4	22	23
Long-Term Deferred Tax Liabilities	1.1	1.1	1.1	1.2	2.2	1.2
Other Long-Term Liabilities	14.6	14.5	4.8	1.9	2.3	2.9
Total Liabilities	906.9	903.3	912	831.9	723.8	689.7
Common Stock	39.6	39.6	39.6	39.6	39.6	39.6
Additional Paid-In Capital	219.8	219.8	219.8	219.8	219.8	219.8
Retained Earnings	253.3	274.5	249.8	113.7	123	185.1
Comprehensive Income & Other	-3.1	-3.2	-10.3	-2	-2	-2.9
Total Common Equity	509.6	530.7	498.9	371.1	380.4	441.6
Shareholders' Equity	509.6	530.7	498.9	371.1	380.4	441.6
Total Liabilities & Equity	1,417	1,434	1,411	1,203	1,104	1,131
Total Debt	668.7	671.8	689.8	644.1	531.2	488.2
Net Cash (Debt)	-626.9	-552.3	-571.3	-515.1	-418.1	-404.6
Net Cash Per Share	-15.94	-13.96	-14.44	-13.02	-10.57	-10.22
Filing Date Shares Outstanding	38.91	39.57	39.57	39.57	39.57	39.57
Total Common Shares Outstanding	38.91	39.57	39.57	39.57	39.57	39.57
Working Capital	628.6	649.4	371.2	489.2	415.8	450.7
Book Value Per Share	13.10	13.41	12.61	9.38	9.61	11.16
Tangible Book Value	493.3	523	490.8	361.5	370	430.2
Tangible Book Value Per Share	12.68	13.22	12.40	9.14	9.35	10.87
Land	-	324	322.6	318	315.9	311.5
Machinery	-	375	339.1	335.6	443.9	157.2
Order Backlog	-	68.2	110.2	98.8	53.9	89.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.